Editors’ Picks: November Highlights from the AACR Journals
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
As the deep reds and yellows of fall leaves give way to twinkling holiday lights, we welcome the new...
Ancient Greek physician Hippocrates considered the human body to be a system composed of four balanced fluids, or “humours.”...
With a five-year survival rate of only 12.5%, any progress toward new therapeutic approaches for pancreatic cancer is welcomed...
Our immune systems are equipped to recognize and destroy cancer cells—if they can find them, that is. And with...
Cancers are driven by unique genetic alterations, so what if we targeted these alterations to treat the cancer? It seems...
For our readers who enjoy learning about the newest tools and strategies in cancer research, the second installment of...
Neuroblastoma, a rare cancer that occurs primarily in children, is a scientific paradox, said pediatric oncologist John M. Maris,...
The AACR Annual Meeting 2023, held April 14-19, commemorated several milestones, including the 25th anniversary of the approval of...
As the temperatures start to drop and the leaves begin to change color, enjoy the latest selection of studies...
FDA approvals issued in third quarter 2023 included a new treatment for prostate cancer harboring BRCA mutations, two new...